GAP-134 - CAS# 943134-39-2 Catalog No.:M10439-2 1 day after administration

1 day after administration

5-Carboxyfluorescein

Flt-3 and FGFR3 kinases which have been shown to play important roles in the pathology of several cancers

3)27-14-15-12-22(17-6-4-5-7-18(17)23(15)29)28-20-10-11-26-21-13-16(25)8-9-19(20)21

GAP-134 - CAS# 943134-39-2 Catalog No.:M10439-2 1 day after administrationDanegaptide, also known as GAP 134 and ZP1609, is an orally active small molecule gap junction modifier for the treatment of atrial fibrillation. Danegaptide mproves conduction and reduces atrial fibrillation flutter in the canine sterile pericarditis model. Danegaptide prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia reperfusion injury in open chest dogs. Product information CAS Number: 943134 39 2